HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study.

AbstractRATIONALE:
Individuals with sleep-disordered breathing (SDB) are at increased cardiovascular risk, possibly due to SDB-related stresses contributing to atherosclerosis.
OBJECTIVES:
We postulate that pathways associated with a prothrombotic potential are up-regulated in SDB.
METHODS:
Morning and evening plasminogen activator inhibitor-1 (PAI-1), morning fibrinogen, and morning D-dimer were measured in 537 Cleveland Family Study adults. Piecewise multivariable linear mixed models estimated relative mean change or mean change in the biomarker per 5-unit increase in apnea-hypopnea index (AHI) in two groups: AHI less than 15 and AHI greater than or equal to 15, and hypoxia defined as percentage of sleep time with Sa(O(2)) less than 90% (< 2%, ≥ 2%).
MEASUREMENTS AND MAIN RESULTS:
Nonlinear associations were demonstrated: morning and evening PAI-1 increased by 12% (95% confidence interval [CI], 5-20%; P < 0.001) and 11% (95% CI, 2-20%; P = 0.01), respectively per 5-unit AHI increase until an AHI of 15, when no further increase in PAI-1 was demonstrated. The association between AHI and morning PAI-1 remained significant after adjusting for evening PAI-1 level (10%; 95% CI, 3-17%; P < 0.01). Morning fibrinogen increased on average by 8.4 mg/dl (95% CI, 3.12-13.65; P = 0.002) per five-unit AHI increase until an AHI of 15. There was no association between AHI and morning D-dimer. Hypoxia severity was not associated with thrombotic marker levels.
CONCLUSIONS:
PAI-1 and fibrinogen levels increase monotonically with AHI at degrees of SDB considered mildly to moderately abnormal, suggesting that even mild SDB levels may increase prothrombotic processes. There may be a plateau in this effect, occurring at levels considered to reflect only moderate SDB severity. These relationships with mild-to-moderate SDB were not observed with D-dimer.
AuthorsReena Mehra, Fang Xu, Denise C Babineau, Russell P Tracy, Nancy S Jenny, Sanjay R Patel, Susan Redline
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 182 Issue 6 Pg. 826-33 (Sep 15 2010) ISSN: 1535-4970 [Electronic] United States
PMID20508215 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • Plasminogen Activator Inhibitor 1
  • fibrin fragment D
  • Fibrinogen
Topics
  • Adult
  • Biomarkers (analysis, blood)
  • Cross-Sectional Studies
  • Family Health
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Fibrinogen (analysis)
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Ohio
  • Plasminogen Activator Inhibitor 1 (blood)
  • Risk Factors
  • Severity of Illness Index
  • Sleep Apnea Syndromes (blood)
  • Thrombosis (blood)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: